Ashland Inc.
Delivering pharmaceutical and nutraceutical performance, Ashland provides solutions for applications in tablet binding, film coating and disintegration, controlled-release formulation and drug solubilization.
Delivering pharmaceutical and nutraceutical performance, Ashland provides solutions for applications in tablet binding, film coating and disintegration, controlled-release formulation and drug solubilization. Ashland creates value for customers through bioavailability enhancement, applications knowledge, regulatory support and a powerful product portfolio. We’re proud to celebrate Klucel™ hydroxypropylcellulose (HPC), a compound so versatile it changed the way the pharmaceutical industry produced oral dosage forms.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
